Phylos

Phylos is a US-based startup that is revolutionizing the cannabis and hemp industry through data-driven science. Founded in 2014, the company aims to support growers with the highest quality and most cost-effective seeds for cannabis production. Phylos recently secured a $1.00M Convertible Note investment from OrganiGram on 24 July 2024, highlighting investor confidence in the company's potential. The startup's focus on Agriculture and Biotechnology industries reflects its commitment to innovation in traditional agricultural practices.

Phylos' slogan, "Unlocking the potential of cannabis and hemp through data-driven science," encapsulates its mission to harness scientific advancements in genetics and cultivation. The company offers the industry's first Production-Ready Seed™, characterized by premium quality, phenotypic stability, and exceptional flower potency and yield. Moreover, Phylos leverages proprietary technologies and expertise in cultivation, extraction, and formulation to provide partners with unparalleled THCV genetics and safe, natural ingredients. Overall, Phylos is positioned to make significant contributions to the commercial-scale cultivation of cannabis, aligning with the growing demand for high-quality products in this evolving market.